Navigation Links
Former EPA official calls for new environmental and consumer protection agency
Date:4/28/2009

Existing health and safety agencies are unable to cope with the risk assessment, standard setting and oversight challenges of advancing nanotechnology. The nation needs a new agency to address current forms of pollution and to deal with the health and environmental impacts of the technically complex products promised by rapid 21st century scientific advances.

In a landmark paper, Oversight of Next Generation Nanotechnology, J. Clarence (Terry) Davies calls for a new Department of Environmental and Consumer Protection to oversee product regulation, pollution control and monitoring, and technology assessment.

According to Davies, "Federal regulatory agencies already suffer from under-funding and bureaucratic ossification, but they will require more than just increased budgets and minor rule changes to deal adequately with the potential adverse effects of new technologies. New thinking, new laws and new organizational forms are necessary. Many of these changes will take a decade or more to accomplish, but there is an urgent need given the rapid pace of technological change to start thinking about them now."

In the 21st century governments face emerging technologies that enable common materials and chemicals to be manipulated in sophisticated ways at the nanoscale, which may pose unknown and not yet understood risks to human health and the environment. These novel materials improve performance of almost any product imaginable, from cosmetics to car batteries to cancer treatments, but little is know about the risks they may pose and there are many questions concerning their life-cycle impact.

"The idea for a new environmental and consumer protection agency may seem far-fetched to some, but before the creation of EPA in 1970 the idea of an organization dedicated to regulating pollutants harmful to human health and the environment also seemed far-fetched," says David Rejeski, the director of the Project on Emerging Nanotechnologies. "Today, agencies like EPA and the Consumer Product Safety Commission lack the resources and tools needed to address the challenges posed by products enabled by advancing nanotechnology and synthetic biology."

In the report's preface, first EPA administrator William D. Ruckelshaus points out that the new Department of Environmental and Consumer Protection outlined in the paper "would be more of a science agency than the current regulatory ones and would incorporate more integrated approaches to oversight and monitoring."

The proposed agency would foster more integrated oversight and a unified mechanism for product regulation to deal with current problems like toxics in children's toys and newer challenges like nanotechnology. A more integrated approach to pollution control was necessary even before EPA was created, and since that time the need has only increased, according to Davies.

"Almost forty years ago, EPA greatly changed governance and regulation of the damage humans do to the environment," Rejeski says. "But now, nearly a decade into the new century, the U.S. needs to take a bold step forward and address pollution and exposure in a more holistic and proactive manner. A new agency with a new vision and mission is needed to ensure technological innovation with minimal environmental impact."


'/>"/>

Contact: Colin Finan
colin.finan@wilsoncenter.org
202-691-4321
Project on Emerging Nanotechnologies
Source:Eurekalert

Related biology technology :

1. Cliff Consulting, Inc. Adds Former Banking IT Executive Ashok Moorthy to Its Team
2. Former GE Healthcare Director, Per Foss Appointed CEO for HUNT Biosciences
3. Pepscan Achieves a Breakthrough With CLIPS Immunogen Technology: Synthetic Peptide Antigen is Able to Induce Fully Functional Antibodies Against a Formerly Intractable GPCR Target CXCR7
4. Lakewood-Amedex, Inc. Appoints William J. Robison, Former Executive Vice President of Pfizer, as Board Member
5. Former President of Sports Cardiology Consultants, LLC Christine Lawless, MD, MBA, ABCL, FACC, FACSM, Named Medical Director of CME Enterprise
6. Micromet Adds Former Head of Roche Oncology Kapil Dhingra, MD to Board of Directors
7. Former SADMERC Medical Directors Join OrthoCare Innovations as Medical and Scientific Advisory Board Members and Strategic Advisors
8. Cyntellect Appoints Former Millipore and BD Biosciences Executives to Head Up its Product Marketing Efforts
9. Cyntellect Appoints Former BD Biosciences Executive Andre Lubarsky as Director of Sales - North America
10. Cynvec LLC(SM) Appoints Former Johnson & Johnson Executive Frank D. Stonebanks as President and Chief Executive Officer
11. Kendle Reappoints Former CFO Timothy M. Mooney to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... 17, 2017  BioGenex, a global leader in ... a novel system for quantitative immunohistochemistry (IHC). The ... of Rochester (NY, USA) and Konica-Minolta Inc. ( ... is able to accurately quantify the expression of ... growth factor receptor-2) in clinical samples. Quantitative IHC ...
(Date:2/16/2017)... Ann Arbor, MI (PRWEB) , ... February 16, 2017 , ... ... between 5:00-7:00 p.m. The event will be held at Avomeen Analytical Services (4840 ... hosted by a MichBio member organization. They provide an opportunity to interact with peers, ...
(Date:2/16/2017)... 16, 2017 Research and Markets ... Global Markets" report to their offering. ... ... biobrick parts, delivery plasmids, chassis organisms, synthetic cells, production ... genome editing, bioinformatics and specialty media) and enabled technologies ...
(Date:2/16/2017)... 16, 2017  Dermata Therapeutics, LLC, a biotechnology ... a variety of dermatological diseases, today announced it ... and entered into a $5 million credit facility ... use the capital for general corporate purposes to ... the treatment of serious diseases treated by dermatologists. ...
Breaking Biology Technology:
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, LLC, ... for the treatment of bacterial infections, today announced ... antibacterial candidates from Pro Bono Bio Ltd (PBB) ... of multi-drug resistant forms of Gram-negative bacteria.   The ... Infectives Ltd, a PBB group company. ...
(Date:1/24/2017)... NEW YORK , Jan. 24, 2017 /PRNewswire/ ... market study of the laboratory use of nuclear ... of 363 experienced end-users and profiled current practices, ... three years, as well as growth and opportunities. ... NMR, Instrument suppliers, NMR instruments, needs and innovation ...
(Date:1/19/2017)... 2017 Sensory Inc ., a ... for consumer electronics, and i nnerCore ... cybersecurity solutions, today announced a global partnership that ... worldwide to bolster security of data sensitive mobile ... authentication platforms they offer, innerCore now offers its ...
Breaking Biology News(10 mins):